Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Grifols
Grifols
Activities:
Manufacturing
Ingredients
Research & Development
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Pharmaceutical
Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo over next seven years
Yimmugo will be followed by other proteins in the pipeline, including fibrinogen and trimodulin, both in late-stage development
Regulatory
Biotest’s Yimmugo receives FDA approval to treat primary immunodeficiencies
The immunoglobulin therapeutic has now been approved for treating primary immunodeficiencies in the US, following its acceptance into the European market
Regulatory
Grifols Procleix ArboPlex arbovirus screening assay receives CE mark
The assay can detect four major arboviruses: chikungunya, dengue, West Nile and Zika
Manufacturing
Spanish technology collaboration focuses on manufacturing equipment
Grifols and Mondragon will work on jointly developing medical and pharmaceutical-related automation, robotics and instrumentation
Manufacturing
Grifols to exhibit at CPhI Worldwide 2017
Grifols Partnership is a business to business contract development and manufacturing platform that specialises in small molecules intravenous solutions for the pharmaceutical industry
Design & Build
Grifols opens US$100m worldwide operations facility in Dublin, Ireland
Will contain a warehouse and handle labelling, packaging and final conditioning for plasma, intermediate and finished product
Design & Build
ISD completes cold storage facility for Spanish pharmaceutical firm Grifols
The 12-month project involved the design and construction of two temperature-controlled self-supporting structures
Subscribe now